Anner H., Kaufman RP, Kobzik L., Valeri CR, Shepro D., Hechtman HBPulmonary hypertension and leukosequestration after lower torso ischemia . Ann Surg206:642-648, 1987.
3.
Howard ML, Bynoe RP, Bell RM, Miles WS, Rush DSIschemia-reperfusion injury of skeletal muscle: Prevention of myocardial depression by venous effluent hemofiltration. Surg Forum42:335-336, 1991.
4.
Hearse DJ, Humphrey SM, Chain EBAbrupt reoxygenation of the potassium-arrested perfused rat heart: A study of myocardial enzyme release. J Mol Cell Cardiol5:395-407, 1973.
5.
Hearse DJ, Humphrey SM, Nayler WG, Slade A., Border D.Ultrastructural damage associated with reoxygenation of anoxic myocardium . J Mol Cell Cardiol7:315-324, 1975.
6.
Braunwald E. , Kloner RAMyocardial reperfusion: A double edged sword ? J Clin Invest76:1713-1719, 1985 .
7.
Shen AC, Jennings RBMyocardial calcium and magnesium in acute ischemic injury. Am J Pathol67:441-452, 1972.
8.
Linas SL, Shanley PF, Whittenberg D., Berger E., Repine JENeutrophils accentuate ischemia-reperfusion injury in isolated perfused rat kidneys. Am J Physiol255:F728-F735, 1988.
9.
Paller MS, Hoidal JR, Ferris TFOxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest74:1156-1164, 1984 .
10.
Adkinson D. , Hoellwarth ME, Benoit JN, Parks DA, McCord JM, Granger DNRole of free radicals in ischemia-reperfusion injury to the liver. Acta Physiol Scand Suppl548: 101-107, 1986.
11.
Jaeschke H. , Farhood A., Smith CW Neutrophils contribute to ischemia/reperfusion injury in the rat liver in vivo. FASEB J4:3355-3359, 1990.
12.
Watson BD, Busto R., Goldberg WJ, Santiso M., Yoshida S., Ginsberg MDLipid peroxidation in vivo induced by reversible global ischemia in rat brain . J Neurochem42: 268-274, 1984.
13.
Parks DA, Granger DNIschemia-induced vascular changes: Role of xanthine oxidase and hydroxyl radical . Am J Physiol245:G285-G289, 1983.
14.
Parks DA, Bulkley GB, Granger DN, Hamilton SR, McCord JMIschemic injury in the cat small intestine: Role of superoxide radicals . Gastroenterology82:9-15, 1982.
15.
Messina LM, Faulkner, JAThe skeletal muscle. In Zelenock GB , ed. Clinical Ischemic Syndromes: Mechanisms and Consequences of Tissue Injury. St. Louis: CV Mosby, 1989, pp 457-481.
16.
Labbe R., Lindsay T., Walker PMThe extent and distribution of skeletal muscle necrosis after graded periods of complete ischemia. J Vasc Surg6:152-157, 1987.
17.
Long JW Jr, Laster JL, Stevens RP, Corkins M., Silver WP, Silver D.Postischemic reperfusion injury in skeletal muscle: Role of oxygen free radicals. Surg Forum39: 342-344, 1988.
Suval WD, Hobson RW II, Boric MP, Ritter AB, Duran WN. Assessment of ischemiareperfusion injury in skeletal muscle by macromolecular clearance. J Surg Res42:550-559, 1987.
23.
Klausner JM , Paterson IS, Goldman G., Kobzik L., Valeri R., Shepro D., Hechtman HBThromboxane A2 mediates increased pulmonary microvascular permeability following limb ischemia. Circ Res64:1178-1189, 1989 .
24.
Klausner JM , Paterson IS, Kobzik L., Valeri CR, Shepro D., Hechtman HBLeukotrienes but not complement mediate limb ischemia-induced lung injury. Ann Surg209:462-470, 1989.
25.
Welbourn CRB , Goldman G., Paterson IS, Valeri CR, Shepro D., Hechtman HBNeutrophil elastase and oxygen radicals: Synergism in lung injury after hindlimb ischemia. Am J Physiol260:H1852-H1856, 1991.
26.
Baker GL, Corry RJ, Autor APOxygen free radical induced damage in kidneys subjected to warm ischemia and reperfusion. Ann Surg202:628-641, 1985.
27.
Flamm E., Demopoulous H., Seligman M., Poser RG, Ransoff J.Free radicals in cerebral ischemia. Stroke9:445-447, 1978.
28.
Parks D., Bulkley GB, Granger DNRole of oxygen-derived free radicals in digestive tract diseases. Surgery94:415-422, 1983.
29.
Parks DA, Bulkley GB, Granger DNRole of oxygen free radicals in shock ischemia and organ preservation . Surgery94:428-432, 1983.
30.
Manson PN, Athenelli MA, Im MJ, Bulkley GB, Hoopas JEThe role of oxygen radicals in ischemic tissue injury in island skin flaps . Ann Surg198:87-90, 1983.
31.
Jolly S., Kane J., Baillie G., Lucceshi R.Canine myocardial reperfusion injury: Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res54: 277-285, 1984.
32.
Fantini GA, Minei JP, Perry MO, Shiono S., Shires GTReperfusion with superoxide dismutase improves cellular membrane function in postischemic skeletal muscle. Surg Forum38:317-319, 1987.
Lee KR, Cronenwett JL, Shlafer M., Corpron C., Zelenock GBEffect of superoxide dismutase plus catalase on Ca2+ transport in ischemic and reperfused skeletal muscle. J Surg Res42:24-32, 1987.
35.
Perry MO, Fantini G. Ischemia: Profile of an enemy: Reperfusion injury of skeletal muscle. J Vasc Surg6:231-234, 1987.
36.
Walker PM, Lindsay TF, Labbe R., Mickle DA, Romaschin ADSalvage of skeletal muscle with free radical scavengers. J Vasc Surg5:68-75, 1987.
37.
Harris K., Walker PM, Mickle AG, Harding R., Gatley R., Wilson GJ, Kuzon B., McKee N., Romaschin ADMetabolic response of skeletal muscle to ischemia. Am J Physiol250: H213-H220, 1986.
38.
Romaschin AD , Rebeyka I., Wilson GJ, Mickle DAG.Conjugated dienes in ischemic and reperfused myocardium: An in vivo chemical signature of oxygen free radical—mediated injuryJ Mol Cell Cardiol19:289-302, 1987.
Yoshioka T. , Shires GT, Fantini GAHypothermia relieves oxidative stress in reperfused skeletal muscle following partial ischemia . J Surg Res1992 (in press).
41.
Halliwell B. , Gutteridge JMC.The importance of free radicals and catalytic metal ions in human diseases. Mol Aspects Med8:89-193, 1985.
42.
Fridovich T.The biology of oxygen radicals. Science201:875-880, 1978.
43.
Del Maestro RFAn approach to free radicals in medicine and biology. Acta Physiol Scand Suppl492:153-168, 1980.
44.
Burton GW, Ingold KUAutoxidation of biological molecules. I. The antioxidant activity of vitamin E and related chain breaking phenolic antioxidants in vitro. J Am Chem Soc103:6472-6477, 1981 .
45.
Halliwell B. , Gutteridge JMC.Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J219:1-14, 1984.
46.
Freeman BA, Crapo JDBiology of disease: Free radicals and tissue injury. Lab Invest47: 412-426, 1982.
47.
Marridonneau I., Braquet P., Garay P.Na + and K + transport damage induced by oxygen free radicals in human red cell membranes. J Biol Chem258:3107-3113, 1983.
48.
Fisher ABIntracellular production of oxygen-derived free radicals. In Halliwell B, ed. Oxygen Radicals and Tissue Injury. Bethesda, Md.: Federation of American Societies for Experimental Biology, 1987, pp 34-39.
49.
Ibrahim B., Stoward PJThe histochemical localization of xanthine oxidase. Histochem J10:615-617, 1978.
50.
Jarasch ED, Grund C., Bruder G., Heid HH, Keenan TW, Franke WWLocalization of xanthine oxidase in mammary gland epithelium and capillary endothelium. Cell25:67-82, 1981.
51.
Stirpe F., Della Corte E.The regulation of rat liver xanthine oxidase. Conversion in vitro of the enzyme activity from dehydrogenase (type D) to oxidase (type O). J Biol Chem244: 3855-3863, 1969 .
52.
Granger DN, Rutili G., McCord JMRole of superoxide radicals in intestinal ischemia. Gastroenterology81:22-29, 1981.
53.
Parks DA, Granger DNXanthine oxidase: Biochemistry, distribution, and physiology. Acta Physiol Scand Suppl548:87-89, 1986.
54.
Engerson TE , McKelvey TG, Rhyne DB, Boggio EB, Snyder SJ, Jones HPConversion of xanthine dehydrogenase to oxidase in ischemic rat tissues. J Clin Invest79:1564-1570, 1987.
55.
Roy RS, McCord JMSuperoxide and ischemia: Conversion of xanthine dehydrogenase to xanthine oxidase. In Greenwald R, Cohen G, eds. Proceedings of the Third International Conference on Superoxide and Superoxide Dismutases . New York: Elsevier, 1983, pp 143-153.
56.
Smith JK, Carden DL, Grisham MB, Granger DN, Korthuis RJRole of iron in postischemic microvascular injury. Am J Physiol256:H1472-H1477, 1989.
57.
Smith JK, Grisham MB, Granger DN, Korthuis RJFree radical defense mechanisms and neutrophil infiltration in postischemic skeletal muscle. Am J Physiol256:H789-H793, 1989.
58.
Cambria RA, Anderson RJ, Dikdan G., Teehan EP, Hernandez-Maldonado JJ, Hobson RW II. Leukocyte activation in ischemia-reperfusion injury of skeletal muscle. J Surg Res51:13-17, 1991.
59.
Klausner JM , Paterson IS, Valeri CR, Shepro D., Hechtman HBLimb ischemia-induced increase in permeability is mediated by leukocytes and leukotrienes. Ann Surg208: 755-760, 1988.
60.
Yokota J., Minei JP, Fantini GA, Shires GTRole of leukocytes in reperfusion injury of skeletal muscle after partial ischemia. Am J Physiol257:H1068-H1075, 1989.
61.
Korthuis RJ , Grisham MB, Granger DNLeukocyte depletion attenuates vascular injury in postischemic skeletal muscle. Am J Physiol254:H823-H827, 1988.
62.
Carden DL, Smith JK, Korthuis RJNeutrophil-mediated microvascular dysfunction in postischemic canine skeletal muscle: Role of granulocyte adherence. Circ Res66: 1436-1444, 1990.
63.
Belkin M., LaMorte ML, Wright JG, Hobson RW The role of leukocytes in the pathophysiology of skeletal muscle ischemic injury. J Vasc Surg10:14-17, 1989.
64.
Fong KL, McKay PB, Poyer JL, Keele BB, Misra H.Evidence that peroxidation of lysosomal membranes is initiated by hydroxyl free radicals produced during flavin enzyme activity. J Biol Chem248:7792-7796, 1973.
65.
Haber F., Weiss J.The catalytic decompensation of hydrogen peroxide by iron salts. Proc R Soc Lond147:332-351, 1934.
66.
Aust SD, Svingen BAThe role of iron in enzymatic lipid peroxidation. In Pryor WA, ed. Free Radicals in Biology . New York: Academic Press, 1982, pp 1-28.
67.
van Asbeck BSOxygen toxicity: Role of hydrogen peroxide and iron. Adv Exp Med Biol264:235-246, 1990.
68.
Bernat I.Iron Metabolism. New York: Plenium Press, 1983, p 415.
69.
Thiel ECFerritin: Structure, gene regulation, and cellular function in animals, plants, and microorganisms. Annu Rev Biochem56:289-315, 1987.
70.
Crichton RR , Roman F., Roland F., Paques E., Paques A., Vandamme E.Ferritin iron deposition and mobilisation . J Mol Catal7:267-276, 1980.
71.
Jones T., Spencer R., Walsh C.Mechanism and kinetics of iron release from ferritin by dihydroflavins and dihydroflavin analogs. Biochemistry17:4011-4017, 1978.
72.
Mazur A., Baez S., Shorr E.The mechanism of iron release from ferritin as related to its biological properties . J Biol Chem213:147-160, 1955.
73.
Janoff A., Zweifach BW, Shapiro LRLevels of plasma-bound iron in experimental shock in the rabbit and dog. Am J Physiol198:1161-1165, 1960 .
74.
Holt S., Gunderson M., Joyce K., Nayini NR, Eyster GF, Garitano AM, Zonia C., Krause GS, Aust SD, White BCMyocardial tissue iron delocalization and evidence for lipid peroxidation after two hours of ischemia. Ann Emerg Med15:1155-1159, 1986.
75.
Komara JS, Nayini NR, Bialick HA, Indrieri RJ, Evans AT, Garritano AM, Hoehner TJ, Jaobs WA, Huang RR, Krause GS, White BC, Aust SDBrain iron delocalization and lipid peroxidation following cardiac arrest . Ann Emerg Med15:384-389, 1986.
76.
Krause GS, Joyce KM, Nayini NR, Zonia CL, Garritano AM, Hoehner TJ, Evans AT, Indreri RJ, Huang RR, Aust SD, White BCCardiac arrest and resuscitation: Brain iron delocalization during reperfusion . Ann Emerg Med14:1037-1043, 1985 .
77.
Robinson E., Hedlund B.Role of iron in ischemia and reperfusion. Circ Shock27:367, 1989.
78.
Paller MS, Hedlund BERole of iron in postischemic renal injury in the rat. Kidney Int34:474-480, 1980.
79.
Gower JD, Healing G., Fuller BJ, Green CJIron redistribution and lipid peroxidation in the cold ischaemic kidney . Ady Exp Med Biol264:393-396, 1990.
80.
Mazur A., Green S., Saha A., Carleton A.Mechanism of release of ferritin iron in vivo by xanthine oxidase . J Clin Invest37:1809-1817, 1958 .
81.
Mazur A., Carleton A.Hepatic xanthine oxidase and ferritin iron in the developing rat. Blood26(3):317-322, 1965.
82.
Green S., Mazur A.Relation of uric acid metabolism to release of iron from hepatic ferritin . J Biol Chem219:653-658, 1957.
83.
Biemond P., van Eijk HG, Swaak AJG, Koster JFIron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes: Possible mechanism in inflammation diseases . J Clin Invest73:1576-1579, 1984 .
84.
Biemond P., Swaak AJG, Beindorff CM, Koster JFSuperoxide-dependent and independent mechanisms of iron mobilization from ferritin by xanthine oxidase. Biochem J239: 169-173, 1986.
85.
Thomas CE, Morehouse LA, Aust SDFerritin and superoxide-dependent lipid peroxidation. J Biol Chem260(6):3275-3280, 1985 .
86.
Bolann BJ, Ulvik RJRelease of iron from ferritin by xanthine oxidase: Role of the superoxide radical. Biochem J243:55-59, 1987.
87.
Smith SM, Grisham MB, Manci EA, Granger DN, Kvietys PRGastric mucosal injury in the rat: Role of iron and xanthine oxidase . Gastroenterology92:950-956, 1987.
88.
Lutz J., Augustin A., Friedrich E.Severity of oxygen free radical effects after ischemia and reperfusion in intestinal tissue and the influence of different drugs. Adv Exp Med Biol277:683-690, 1990.
89.
Hernandez LA , Grisham MB, Granger DMA role for iron in oxidant-mediated ischemic injury to intestinal microvasculatureAm J Physiol253:G49-G53, 1987.
90.
Omar R., Nomikos I., Piccorelli G., Savino J., Agarwal N.Prevention of postischemic lipid peroxidation and liver cell injury by iron chelation. Gut30(4):510-514, 1989.
91.
Baron P., Gomez-Marin O., Casas C., Heil J., Will N., Condie R., Burke B., Najarian JS, Sutherland DERenal preservation after warm ischemia using oxygen free radical scavengers to prevent reperfusion injury. J Surg Res51:60-65, 1991.
92.
Green CJ, Healing G., Simpkin S., Lunec J., Fuller BJDesferrioxamine reduces susceptibility to lipid peroxidation in rabbit kidneys subjected to warm ischemia and reperfusion. J Comp Biochem Physiol85B:113-1171986.
93.
Menasche P. , Pasquier C., Bellucci S., Lorente P., Jaillon P., Piwnica A.Deferoxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in man. J Thorac Cardiovasc Surg96:582-589, 1988.
94.
Bolli R., Patel BS, Zhu WX, O'Neill PG, Charlat ML, Roberts R.The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction . Am J Physiol253: H1372-H1380, 1987.
95.
Farber NE, Vercellotti GM, Jacob HS, Pieper GM, Gross GJEvidence for a role of iron-catalyzed oxidants in functional and metabolic stunning in the canine heart. Circ Res63:351-360, 1988.
96.
Badylak SF, Simmons A., Turek J., Babbs CFProtection from reperfusion injury in the isolated rat heart by postischemic deferoxamine and oxypurinol administration. Cardiovasc Res21:500-506, 1987.
97.
Ambrosio G., Zweier JL, Jacobus WE, Weisfelt ML, Flaherty JTImprovement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: The role of iron in the pathogenesis of reperfusion injury. Circulation76:906-915, 1987.
98.
Lesnefsky EJ , Repine JE, Horwitz LDDeferoxamine pretreatment reduces canine infarct size and oxidative injury . J Pharmacol Exp Ther253(3):1103-1109, 1990.
99.
Williams RE , Zweier JL, Flaherty JTTreatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts. Circulation83(3):1006-1014, 1991.
100.
Conte JV Jr, Katz NM, Foegh ML, Wallace RB, Ramwell PW Iron chelation therapy and lung transplantation. Effects of deferoxamine on lung preservation in canine single lung transplantation. J Thorac Cardiovasc Surg101(6):1024-1029, 1991.
101.
Angel MF, Narayanan K., Swartz WM, Ramasastry SS, Basford RE, Kuhns DB, Futrell JW The etiologic role of free radicals in hematoma-induced flap necrosis . Plast Reconstr Surg77(5):795-801, 1986.
102.
Angel MF, Narayanan K., Swartz WM, Ramasastry SS, Kuhns DB, Basford RE, Futrell JWDeferoxamine increases skin flap survival: Additional evidence of free radical involvement in ischemic flap surgery. Br J Plast Surg39:469-472, 1986.
103.
Angel MF, Mellow CG, Knight KR, O'Brien BMThe effect of deferoxamine on tolerance to secondary ischemia caused by venous obstruction. Br J Plast Surg42:422-424, 1989.
104.
Weinstein GS, Maves MD, McCormack MLDeferoxamine decreases necrosis in dorsally based pig skin flaps. Otolaryngol Head Neck Surg101(5):559-561, 1989.
105.
Halliwell B.Protection against tissue damage in vivo by desferrioxamine: What is its mechanism of action?Free Radic Biol Med7:645-651, 1989.
106.
Perler BA, Tohmeh AG, Bulkley GBInhibition of the compartment syndrome by the ablation of free radical-mediated reperfusion injury. Surgery108(1):40-47, 1990.
107.
Bolli R., Jeroudi MO, Patel BS, Aruoma OI, Halliwell B., Lai EK, McKay PBMarked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion: Evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ Res65:607-622, 1989.
108.
Bernier M. , Manning AS, Hearse DJReperfusion arryhthmias: Dose related protection by anti-free radical interventions. Am J Physiol256:H1344-H1352, 1989.
109.
Omar BA, Gad NM, Jordan MC, Striplin SP, Russell WJ, Downey JM, McCord JMCardioprotection by Cu, Zn-superoxide dismutase is lost at high doses in the reoxygenated heart. Free Radic Biol Med9:465-471, 1990.
110.
Omar BA, McCord JMThe cardioprotective effect of Mn-superoxide dismutase is lost at high doses in the postischemic isolated rabbit heart. Free Radic Biol Med9:473-478, 1990.
111.
Hallaway PE , Eaton JW, Panter SS, Hedlund BEModulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers. Proc Natl Acad Sci USA86: 10108-10112, 1989.
112.
deLemos RA , Roberts RJ, Coalson JJ, deLemos JA, Null DM Jr, Gerstmann DRToxic effects associated with the administration of deferoxamine in the premature baboon with hyaline membrane disease. Am J Dis Child144:915-919, 1990.
113.
Forder JR, McClanahan TB, Gallagher KP, Hedlund BE, Hallaway PE, Shlafer M.Hemodynamic effects of intraatrial administration of deferoxamine or deferoxaminepentafraction conjugate to conscious dogs. J Cardiovasc Pharmacol16:742-749, 1990.
114.
Hedlund BE, Hallaway PE, Mahoney JRHigh molecular weight forms of deferoxamine: Novel therapeutic agents for treatment of iron-mediated tissue injury. Adv Exp Med Biol264:229-234, 1990.
115.
Maruyama M., Pieper GM, Kalyanaraman B., Hallaway PE, Hedlund BE, Gross GJEffects of hydroxyethyl starch conjugated deferoxamine on myocardial functional recovery. J Cardiovasc Pharmacol17:166-175, 1991.
116.
Drugas GT, Paidas CN, Yahanda AM, Ferguson D., Clemens MGConjugated deferoxamine attenuates hepatic microvascular injury following ischemia-reperfusion. Circ Shock34:278-283, 1991.
117.
Rosenthal RE, Chanderbhan R., Granville M., Fiskum G.Prevention of post-ischemic brain lipid conjugated diene production and neurological injury by hydroxyethyl starch-conjugated deferoxamine. Free Radic Biol Med12(1):29-33, 1992.
Jacobsen EJ , McCall JM, Ayer DENovel 21-amino steroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma. J Med Chem33: 1145, 1990 .
120.
Braughler JM, Burton PS, Chase RL, Pregenzer JF, Jacobsen EJ, van Doornik FJ, Tustin JM, Ayer DE, Bundy GLNovel membrane localized iron chelators as inhibitors of iron-dependent lipid peroxidation . Biochem Pharmacol37(20):3853-3860, 1988 .
121.
Braughler JM, Pregenzer JFThe 21-aminosteroid inhibitors of lipid peroxidation: Reactions with lipid peroxyl and phenoxy radicals. Free Radic Biol Med7:125-130, 1989.
122.
Natale JE, Schott RJ, Hall ED, Braughler JM, D'Alecy LGEffect of the aminosteroid U74006F after cardiopumonary arrest in dogs. Stroke19:1371-1378, 1988 .
123.
Hendry PJ, Anstadt MP, Plunkett MD, Amato MD, Menius JA Jr, Lowe JEImproved donor myocardial recovery with a new lazaroid lipid antiperoxidant in the isolated canine heart. J Heart Lung Transplant11(4):636-645, 1992.